Literature DB >> 21791620

Leptin in human physiology and pathophysiology.

Christos S Mantzoros1, Faidon Magkos, Mary Brinkoetter, Elizabeth Sienkiewicz, Tina A Dardeno, Sang-Yong Kim, Ole-Petter R Hamnvik, Anastasia Koniaris.   

Abstract

Leptin, discovered through positional cloning 15 years ago, is an adipocyte-secreted hormone with pleiotropic effects in the physiology and pathophysiology of energy homeostasis, endocrinology, and metabolism. Studies in vitro and in animal models highlight the potential for leptin to regulate a number of physiological functions. Available evidence from human studies indicates that leptin has a mainly permissive role, with leptin administration being effective in states of leptin deficiency, less effective in states of leptin adequacy, and largely ineffective in states of leptin excess. Results from interventional studies in humans demonstrate that leptin administration in subjects with congenital complete leptin deficiency or subjects with partial leptin deficiency (subjects with lipoatrophy, congenital or related to HIV infection, and women with hypothalamic amenorrhea) reverses the energy homeostasis and neuroendocrine and metabolic abnormalities associated with these conditions. More specifically, in women with hypothalamic amenorrhea, leptin helps restore abnormalities in hypothalamic-pituitary-peripheral axes including the gonadal, thyroid, growth hormone, and to a lesser extent adrenal axes. Furthermore, leptin results in resumption of menses in the majority of these subjects and, in the long term, may increase bone mineral content and density, especially at the lumbar spine. In patients with congenital or HIV-related lipoatrophy, leptin treatment is also associated with improvements in insulin sensitivity and lipid profile, concomitant with reduced visceral and ectopic fat deposition. In contrast, leptin's effects are largely absent in the obese hyperleptinemic state, probably due to leptin resistance or tolerance. Hence, another emerging area of research pertains to the discovery and/or usefulness of leptin sensitizers. Results from ongoing studies are expected to further increase our understanding of the role of leptin and the potential clinical applications of leptin or its analogs in human therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791620      PMCID: PMC3191548          DOI: 10.1152/ajpendo.00315.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  287 in total

Review 1.  Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity.

Authors:  Ashwini Oswal; Giles Yeo
Journal:  Obesity (Silver Spring)       Date:  2009-07-30       Impact factor: 5.002

2.  Leptin and the skeleton-where is the fat?

Authors:  Catherine M Gordon
Journal:  Metabolism       Date:  2011-07-13       Impact factor: 8.694

3.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty.

Authors:  C S Mantzoros; J S Flier; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

4.  Acute effects of leptin on glucose metabolism of in situ rat perfused livers and isolated hepatocytes.

Authors:  R B Ceddia; G Lopes; H M Souza; G R Borba-Murad; W N William; R B Bazotte; R Curi
Journal:  Int J Obes Relat Metab Disord       Date:  1999-11

5.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

6.  Hormonal, lifestyle, and dietary factors in relation to leptin among elderly men.

Authors:  P Lagiou; L B Signorello; C S Mantzoros; D Trichopoulos; C C Hsieh; A Trichopoulou
Journal:  Ann Nutr Metab       Date:  1999       Impact factor: 3.374

Review 7.  Leptin in humans: lessons from translational research.

Authors:  Susann Blüher; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

8.  Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset.

Authors:  R E Frisch; J W McArthur
Journal:  Science       Date:  1974-09-13       Impact factor: 47.728

9.  Leptin administration normalizes insulin secretion from islets of Lep(ob)/Lep(ob) mice by food intake-dependent and -independent mechanisms.

Authors:  Joo-Won Lee; Dale R Romsos
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

10.  Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans.

Authors:  Janice J Hwang; Jean L Chan; Georgia Ntali; Dalia Malkova; Christos S Mantzoros
Journal:  Diabetes Care       Date:  2008-02-05       Impact factor: 19.112

View more
  178 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 3.  From PDE3B to the regulation of energy homeostasis.

Authors:  Eva Degerman; Faiyaz Ahmad; Youn Wook Chung; Emilia Guirguis; Bilal Omar; Lena Stenson; Vincent Manganiello
Journal:  Curr Opin Pharmacol       Date:  2011-10-14       Impact factor: 5.547

4.  The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity.

Authors:  M A Vasilenko; E V Kirienkova; D A Skuratovskaia; P A Zatolokin; N I Mironyuk; L S Litvinova
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

5.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Authors:  Giuseppe Matarese; Claudia La Rocca; Hyun-Seuk Moon; Joo Young Huh; Mary T Brinkoetter; Sharon Chou; Francesco Perna; Dario Greco; Holly P Kilim; Chuanyun Gao; Kalliope Arampatzi; Zhaoxi Wang; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 6.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Serum leptin levels and reproductive function during the menstrual cycle.

Authors:  Katherine Ahrens; Sunni L Mumford; Karen C Schliep; Kerri A Kissell; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Am J Obstet Gynecol       Date:  2013-11-08       Impact factor: 8.661

Review 8.  The role of leptin in regulating bone metabolism.

Authors:  Jagriti Upadhyay; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

9.  Diet quality and diet patterns in relation to circulating cardiometabolic biomarkers.

Authors:  Byung-Joon Ko; Kyung Hee Park; Sangah Shin; Lesya Zaichenko; Cynthia R Davis; Judith A Crowell; Hyojee Joung; Christos S Mantzoros
Journal:  Clin Nutr       Date:  2015-04-07       Impact factor: 7.324

Review 10.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.